Differential roles of STAT1alpha and STAT1beta in fludarabine-induced cell cycle arrest and apoptosis in human B cells.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Blood

• Publication date

  2004-10-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/BLOOD-2003-10-3508PMID 15217838
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Real Time Analysis of STAT3 Nucleocytoplasmic Shuttling*

  2004cited by this paper
• STAT-1 Interacts with p53 to Enhance DNA Damage-induced Apoptosis*

  2004cited by this paper
• Standardization and quality control studies of ‘real-time’ quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia – A Europe Against Cancer Program

  2003cited by this paper
• Fludarabine + prednisone +/- alpha-interferon followed or not by alpha-interferon maintenance therapy for previously untreated patients with chronic lymphocytic leukemia: long term results of a randomized study.

  2003cited by this paper
• The resistance of B-CLL cells to DNA damage-induced apoptosis defined by DNA microarrays.

  2003cited by this paper
• Efficacy of fludarabine/mitoxantrone/dexamethasone alternating with CHOP in bulky follicular non-Hodgkin's lymphoma.

  2002cited by this paper
• Phase II study of fludarabine combined with interferon-alpha-2a followed by maintenance therapy with interferon-alpha-2a in patients with low-grade non-hodgkin's lymphoma.

  2002cited by this paper
• Fludarabine, mitoxantrone, dexamethasone (FND) compared with an alternating triple therapy (ATT) regimen in patients with stage IV indolent lymphoma.

  2002cited by this paper
• Gene Array Identification of Epstein Barr Virus-Regulated Cellular Genes in EBV-Converted Burkitt Lymphoma Cell Lines

  2002cited by this paper
• Phase II study of fludarabine combined with interferon-α-2a followed by maintenance therapy with interferon-α-2a in patients with low-grade non-Hodgkin's lymphoma

  2002cited by this paper
• Cellular and Clinical Pharmacology of Fludarabine

  2002cited by this paper
• Resistance to fludarabine-induced apoptosis in Epstein-Barr virus infected B cells

  2002cited by this paper
• Antiviral Response in Cells Containing Stat1 with Heterologous Transactivation Domains

  2001cited by this paper
• Role of Jak Kinases and STATs in Cytokine Signal Transduction

  2001cited by this paper
• Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity.

  2000cited by this paper
• Stat1 as a Component of Tumor Necrosis Factor Alpha Receptor 1-TRADD Signaling Complex To Inhibit NF-κB Activation

  2000cited by this paper
• Regulation of c-myc expression by IFN-gamma through Stat1-dependent and -independent pathways.

  2000cited by this paper
• Regulation of c‐myc expression by IFN‐γ through Stat1‐dependent and ‐independent pathways

  2000cited by this paper
• Interferon-gamma has dual potentials in inhibiting or promoting cell proliferation.

  2000cited by this paper
• Inducible loss of NF-kappaB activity is associated with apoptosis and Bcl-2 down-regulation in Epstein-Barr virus-transformed B lymphocytes.

  2000cited by this paper
• Tet repressor-based system for regulated gene expression in eukaryotic cells: principles and advances.

  2000cited by this paper
• Safety of fludarabine, mitoxantrone, and dexamethasone combined with rituximab in the treatment of stage IV indolent lymphoma.

  2000cited by this paper
• Interferon-γ Has Dual Potentials in Inhibiting or Promoting Cell Proliferation*

  2000cited by this paper
• The Epstein-Barr Virus Nuclear Antigen 2 (EBNA2), a Protein Required for B Lymphocyte Immortalization, Induces the Synthesis of Type I Interferon in Burkitts Lymphoma Cell Lines

  1999cited by this paper
• Loss of STAT1 expression confers resistance to IFN‐γ‐induced apoptosis in ME180 cells

  1999cited by this paper
• Fludarabine-induced immunosuppression is associated with inhibition of STAT1 signaling

  1999cited by this paper
• Loss of STAT1 expression confers resistance to IFN-gamma-induced apoptosis in ME180 cells.

  1999cited by this paper
• The Epstein-Barr virus nuclear antigen 2 (EBNA2), a protein required for B lymphocyte immortalization, induces the synthesis of type I interferon in Burkitt's lymphoma cell lines.

  1999cited by this paper
• Epidermal growth factor-induced growth inhibition requires Stat1 activation.

  1998cited by this paper
• Synergistic activation of p53 by inhibition of MDM2 expression and DNA damage.

  1998cited by this paper
• STAT structure and function in signaling.

  1998cited by this paper
• The Role of Interferon in Influenza Virus Tissue Tropism

  1998cited by this paper
• Regulation of T helper cell differentiation by STAT molecules

  1998cited by this paper
• IFNγ inhibition of cell growth in glioblastomas correlates with increased levels of the cyclin dependent kinase inhibitor p21WAF1/CIP1

  1998cited by this paper
• Epstein-Barr virus LMP1 induction of the epidermal growth factor receptor is mediated through a TRAF signaling pathway distinct from NF-kappaB activation

  1997cited by this paper
• Targeted Inhibition of Interferon-γ-dependent Intercellular Adhesion Molecule-1 (ICAM-1) Expression Using Dominant-Negative Stat1*

  1997cited by this paper
• STATs and gene regulation.

  1997cited by this paper
• Defective TNF-α-Induced Apoptosis in STAT1-Null Cells Due to Low Constitutive Levels of Caspases

  1997cited by this paper
• Transcription factors IRF‐1 and IRF‐2: Linking the immune responses and tumor suppression

  1997cited by this paper
• Defective TNF-alpha-induced apoptosis in STAT1-null cells due to low constitutive levels of caspases.

  1997cited by this paper
• Activation of Statl by mutant fibroblast growth-factor receptor in thanatophoric dysplasia type II dwarfism

  1997cited by this paper
• Activation of the STAT signaling pathway can cause expression of caspase 1 and apoptosis

  1997cited by this paper
• Mapping of Stat3 serine phosphorylation to a single residue (727) and evidence that serine phosphorylation has no influence on DNA binding of Stat1 and Stat3.

  1997cited by this paper
• Tetracycline-controlled transcription in eukaryotes: novel transactivators with graded transactivation potential.

  1997cited by this paper
• DNA binding of in vitro activated Stat1 alpha, Stat1 beta and truncated Stat1: interaction between NH2‐terminal domains stabilizes binding of two dimers to tandem DNA sites.

  1996cited by this paper
• Cell Growth Arrest and Induction of Cyclin-Dependent Kinase Inhibitor p21WAF1/CIP1 Mediated by STAT1

  1996cited by this paper
• Constitutive activation of STAT proteins in primary lymphoid and myeloid leukemia cells and in Epstein-Barr virus (EBV)-related lymphoma cell lines.

  1996cited by this paper
• Transcriptionally active Stat1 is required for the antiproliferative effects of both interferon alpha and interferon gamma.

  1996cited by this paper
• Co-regulation of two gene activities by tetracycline via a bidirectional promoter.

  1995cited by this paper
• Requirement of serine phosphorylation for formation of STAT-promoter complexes.

  1995cited by this paper
• Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation.

  1995cited by this paper
• Cytokine signal transduction.

  1995cited by this paper
• A single phosphotyrosine residue of Stat91 required for gene activation by interferon-gamma.

  1993cited by this paper
• Complementation of a mutant cell line: central role of the 91 kDa polypeptide of ISGF3 in the interferon‐alpha and ‐gamma signal transduction pathways.

  1993cited by this paper
• Activation of transcription by IFN-gamma: tyrosine phosphorylation of a 91-kD DNA binding protein.

  1992cited by this paper
• Expression of the epstein‐barr virus (EBV)‐encoded membrane protein LMP1 impairs the In vitro growth, clonability and tumorigenicity of an EBV‐negative burkitt lymphoma line

  1992cited by this paper
• Functional analysis of defined mutations in the immunoglobulin heavy-chain enhancer in transgenic mice.

  1992cited by this paper
• Proteins of transcription factor ISGF-3: one gene encodes the 91-and 84-kDa ISGF-3 proteins that are activated by interferon alpha.

  1992cited by this paper
• NF-kappa B activation by tumor necrosis factor alpha in the Jurkat T cell line is independent of protein kinase A, protein kinase C, and Ca(2+)-regulated kinases.

  1991cited by this paper
• NF-κB activation by tumor necrosis factor α in the jurkat T cell line is independent of protein kinase A, protein kinase C, and Ca2+-regulated kinases

  1991cited by this paper
• Interferon-alpha regulates nuclear translocation and DNA-binding affinity of ISGF3, a multimeric transcriptional activator.

  1990cited by this paper
• ISGF3, the transcriptional activator induced by interferon alpha, consists of multiple interacting polypeptide chains.

  1990cited by this paper
• Reversion of tumorigenicity and decreased agarose clonability after EBV conversion of an igh/myc translocation‐carrying be line

  1989cited by this paper
• Real time

  1981cited by this paper

• The New Insight Into the Role of Transcription Factors in the Function of Regulatory T Cells With Emphasis on FOXP3 and Its Implication in the Treatment of Autoimmune Disorders

  2026cites this paper
• ASVirus: A Comprehensive Knowledgebase for the Viral Alternative Splicing

  2025cites this paper
• STAT Signature Dish: Serving Immunity with a Side of Dietary Control

  2025cites this paper
• STAT1-mediated epigenetic regulation of LIN28A controls iPSC-derived platelet production through the let-7–RALB axis

  2025cites this paper
• STAT1β modulates the tumor immune microenvironment to improve prognosis in ovarian cancer: a comprehensive study of transcriptional and protein expression differences

  2025cites this paper
• Borrelia burgdorferi sensu lato inhibits CIITA transcription through pSTAT3 activation and enhanced SOCS1 and SOCS3 expression leading to limited IFN-γ production.

  2025cites this paper
• Unraveling the Immunogenetics of STAT Proteins: Clinical Perspectives on Gain-of-Function and Loss-of-Function Variants.

  2024cites this paper
• An Integrated Network Pharmacology and RNA-seq Approach for Exploring the Protective Effect of Andrographolide in Doxorubicin-Induced Cardiotoxicity

  2024cites this paper
• A comprehensive analysis of the expression and prognostic significance of signal transducers and activators of transcription family in gastric cancer patients

  2024cites this paper
• Activation of cellular responses by cyclic dinucleotides and porphyromonas gingivalis lipopolysaccharide: a proteomic study on gingival fibroblasts

  2024cites this paper
• AFDN deficiency promotes liver tropism of metastatic colorectal cancer.

  2024cites this paper
• ABCG2 shields against epilepsy, relieves oxidative stress and apoptosis via inhibiting the ISGylation of STAT1 and mTOR

  2024cites this paper
• Network pharmacology-based strategy to investigate the effect and mechanism of α-solanine against glioma

  2023cites this paper
• Roles of alternative splicing in infectious diseases: from hosts, pathogens to their interactions

  2023cites this paper
• In Silico Bioinformatics Followed by Molecular Validation Using Archival FFPE Tissue Biopsies Identifies a Panel of Transcripts Associated with Severe Asthma and Lung Cancer

  2022cites this paper
• Effect of Nicotine on STAT1 Pathway and Oxidative Stress in Rat Lungs.

  2021cites this paper
• The Dual Role of STAT1 in Ovarian Cancer: Insight Into Molecular Mechanisms and Application Potentials

  2021cites this paper
• IFN-γ contributes to the hepatic inflammation in HFD-induced nonalcoholic steatohepatitis by STAT1β/TLR2 signaling pathway.

  2021cites this paper
• Role of Alternative Splicing in Regulating Host Response to Viral Infection

  2021cites this paper
• Identification and characterization of IRF9 from black carp Mylopharyngodon piceus.

  2020cites this paper
• Sphingosine Kinase 1 Regulates the Survival of Breast Cancer Stem Cells and Non-stem Breast Cancer Cells by Suppression of STAT1

  2020cites this paper
• MLLT6 maintains PD‐L1 expression and mediates tumor immune resistance

  2020cites this paper
• The potential and controversy of targeting STAT family members in cancer.

  2020cites this paper
• STAT1 Isoforms Differentially Regulate NK Cell Maturation and Anti-tumor Activity

  2020cites this paper
• Predicting STAT1 as a prognostic marker in patients with solid cancer

  2020cites this paper
• STAT3beta, a distinct isoform from STAT3.

  2019cites this paper
• STAT1a and STAT1b of black carp play important roles in the innate immune defense against GCRV

  2019cites this paper
• Signal Transducer and Activator of Transcription (STATs) Proteins in Cancer and Inflammation: Functions and Therapeutic Implication

  2019cites this paper
• Lead alters intracellular protein signaling and suppresses pro-inflammatory activation in TLR4 and IFNR-stimulated murine RAW 264.7 cells, in vitro

  2019cites this paper
• Physical interaction of STAT1 isoforms with TGF-β receptors leads to functional crosstalk between two signaling pathways in epithelial ovarian cancer

  2018cites this paper
• Dual inhibition of STAT1 and STAT3 activation downregulates expression of PD-L1 in human breast cancer cells

  2018cites this paper
• ERK is a negative feedback regulator for IFN-γ/STAT1 signaling by promoting STAT1 ubiquitination

  2018cites this paper
• Elucidating the role of JAK/STAT signalling in polycythaemia vera and essential thrombocythaemia using proteomics

  2018cites this paper
• ERK is a negative feedback regulator for IFN-γ/STAT1 signaling by promoting STAT1 ubiquitination

  2018cites this paper
• Two type II IFN members, IFN‐&ggr; and IFN‐&ggr; related (rel), regulate differentially IRF1 and IRF11 in zebrafish

  2017cites this paper
• STAT1β enhances STAT1 function by protecting STAT1α from degradation in esophageal squamous cell carcinoma

  2017cites this paper
• Involvement of STAT1 in proliferation and invasiveness of trophoblastic cells.

  2017cites this paper
• STAT1 in cancer: friend or foe?

  2017cites this paper
• Identification and characterization of differentially expressed genes from human microglial cell samples infected with Japanese encephalitis virus.

  2017cites this paper
• Survival, bacterial clearance and thrombocytopenia are improved in polymicrobial sepsis by targeting nuclear transport shuttles

  2017cites this paper
• The good and the bad faces of STAT1 in solid tumours.

  2017cites this paper
• A STAT 3-inhibitory hairpin decoy oligodeoxynucleotide discriminates between STAT 1 and STAT 3 and induces death in a human colon carcinoma cell line

  2017cites this paper
• Cellular response to alkylating agent MNNG is impaired in STAT1‐deficients cells

  2016cites this paper
• Novel drug targets for personalized precision medicine in relapsed/refractory diffuse large B-cell lymphoma: a comprehensive review

  2015cites this paper
• Inducible, Dose-Adjustable and Time-Restricted Reconstitution of Stat1 Deficiency In Vivo

  2014cites this paper
• Comparison of outcomes of hematopoietic stem cell transplantation without chemotherapy conditioning by using matched sibling and unrelated donors for treatment of severe combined immunodeficiency.

  2014cites this paper
• Comparison of outcomes of hematopoietic stem cell transplant without chemotherapy conditioning using matched sibling and unrelated donors for treatment of SCID

  2014cites this paper
• STAT1β Is Not Dominant Negative and Is Capable of Contributing to Gamma Interferon-Dependent Innate Immunity

  2014cites this paper
• RelA and RelB cross-talk and function in Epstein–Barr virus transformed B cells

  2014cites this paper
• Nouveaux rôles anti-tumoraux de STAT1 : expression des immunoglobulines et réparation de l'ADN

  2014cites this paper
• DTX3L and ARTD9 inhibit IRF1 expression and mediate in cooperation with ARTD8 survival and proliferation of metastatic prostate cancer cells

  2014cites this paper
• BAL1/ARTD9 represses the anti-proliferative and pro-apoptotic IFN&ggr;–STAT1–IRF1–p53 axis in diffuse large B-cell lymphoma

  2013cites this paper
• primary co-cultures by altering the myeloid microenvironment Lenalidomide reduces survival of chronic lymphocytic leukemia cells in

  2013cites this paper
• The pyrimidine analog FNC inhibits cell proliferation and viral protein synthesis in HTLV‑1‑infected cells.

  2013cites this paper
• Activation of Antitumorigenic Stat3beta in Breast Cancer by Splicing Redirection

  2013influential citation
• Lenalidomide reduces survival of chronic lymphocytic leukemia cells in primary cocultures by altering the myeloid microenvironment.

  2012cites this paper
• A STAT3-inhibitory hairpin decoy oligodeoxynucleotide discriminates between STAT1 and STAT3 and induces death in a human colon carcinoma cell line

  2012cites this paper
• Present status and perspectives in functional analysis of p53 in chronic lymphocytic leukemia

  2012cites this paper
• B7-H1, Which Represses EBV-Immortalized B Cell Killing by Autologous T and NK Cells, Is Oppositely Regulated by c-Myc and EBV Latency III Program at Both mRNA and Secretory Lysosome Levels

  2012cites this paper
• Secretory Lysosome Levels Latency III Program at Both mRNA and Is Oppositely Regulated by c-Myc and EBV Cells, B Cell Killing by Autologous T and NK B7-H1, Which Represses EBV-Immortalized

  2012cites this paper
• FNC, a novel nucleoside analogue inhibits cell proliferation and tumor growth in a variety of human cancer cells.

  2011cites this paper
• Signal transducers and activators of transcription-from cytokine signalling to cancer biology.

  2011cites this paper
• The role of stat1b in zebrafish hematopoiesis.

  2011cites this paper
• IL-7 Promotes CD95-Induced Apoptosis in B Cells via the IFN-γ/STAT1 Pathway

  2011cites this paper
• Antitumorigenic potential of STAT3 alternative splicing modulation

  2011cites this paper
• STAT1 and pathogens, not a friendly relationship

  2010cites this paper
• Cladribine and Fludarabine Nucleoside Change the Levels of CD Antigens on B-Lymphoproliferative Disorders

  2010cites this paper
• STAT1‐dependent IgG cell‐surface expression in a human B cell line derived from a STAT1‐deficient patient

  2010cites this paper
• Cytotoxic activity of 2-Fluoro-ara-AMP and 2-Fluoro-ara-AMP-loaded erythrocytes against human breast carcinoma cell lines.

  2010cites this paper
• Dichotomy between factors inducing the immunosuppressive enzyme IL‐4‐induced gene 1 (IL4I1) in B lymphocytes and mononuclear phagocytes

  2010cites this paper
• Inhibition of type I and type II interferon signaling by alphavirus nonstructural proteins

  2010cites this paper
• Epstein-Barr Virus SM Protein Utilizes Cellular Splicing Factor SRp20 To Mediate Alternative Splicing

  2010cites this paper
• DICHOTOMY BETWEEN FACTORS INDUCING THE IMMUNOSUPPRESSIVE ENZYME IL4I1 IN B LYMPHOCYTES AND MONONUCLEAR PHAGOCYTES

  2010cites this paper
• The Epstein–Barr Virus Lytic Life Cycle

  2009cites this paper
• Profiling CD antigens on leukaemias with an antibody microarray

  2009cites this paper
• c-Myc and Rel/NF-κB Are the Two Master Transcriptional Systems Activated in the Latency III Program of Epstein-Barr Virus-Immortalized B Cells

  2009cites this paper
• Impaired up‐regulation of polo‐like kinase 2 in B‐cell chronic lymphocytic leukaemia lymphocytes resistant to fludarabine and 2‐chlorodeoxyadenosine: a potential marker of defective damage response

  2009cites this paper
• Regulation of DNA polymerase beta by the LMP1 oncoprotein of EBV through the nuclear factor-kappaB pathway.

  2009cites this paper
• Probiotics prevent enterohaemorrhagic Escherichia coli O157:H7-mediated inhibition of interferon-gamma-induced tyrosine phosphorylation of STAT-1.

  2009cites this paper
• Molecular Mechanisms of Viral Immune Evasion Proteins to Inhibit MHC Class I Antigen Processing and Presentation

  2009cites this paper
• Flow cytometry APC‐tandem dyes are degraded through a cell‐dependent mechanism

  2009cites this paper
• C-Myc et lymphomagenèse dans les cellules B infectées par le virus d’Epstein-Barr

  2009cites this paper
• Epstein-Barr Virus SM Protein Functions as an Alternative Splicing Factor

  2008cites this paper
• Novel function of STAT1β in B cells: induction of cell death by a mechanism different from that of STAT1α

  2008influential citation
• Molecular Basis of Cytotoxicity of Epstein-Barr Virus (EBV) Latent Membrane Protein 1 (LMP1) in EBV Latency III B Cells: LMP1 Induces Type II Ligand-Independent Autoactivation of CD95/Fas with Caspase 8-Mediated Apoptosis

  2008influential citation
• Identification of a novel p53-dependent activation pathway of STAT1 by antitumour genotoxic agents

  2008cites this paper
• c‐MYC activation impairs the NF‐κB and the interferon response: Implications for the pathogenesis of Burkitt's lymphoma

  2007cites this paper
• c-MYC impairs immunogenicity of human B cells.

  2007cites this paper
• The number of genes changing expression after chronic exposure to Code Division Multiple Access or Frequency DMA radiofrequency radiation does not exceed the false‐positive rate

  2006cites this paper
• Update on the therapy of highly aggressive non-Hodgkin’s lymphoma

  2006cites this paper
• Gene Expression does not Change Significantly in C3H 10T½ Cells after Exposure to 847.74 CDMA or 835.62 FDMA Radiofrequency Radiation

  2006cites this paper
• EBV latency III immortalization program sensitizes B cells to induction of CD95-mediated apoptosis via LMP1: role of NF-kappaB, STAT1, and p53.

  2006cites this paper
• Effect of tumor necrosis factor alpha and infliximab on apoptosis of B lymphocytes infected or not with Epstein-Barr virus.

  2006cites this paper
• Latent Membrane Protein 1 Regulates STAT1 through NF-κB-Dependent Interferon Secretion in Epstein-Barr Virus-Immortalized B Cells

  2005influential citation
• Old and new insights into the mechanisms of action of two nucleoside analogs active in lymphoid malignancies: fludarabine and cladribine (review).

  2005cites this paper
• Intracellular interferon triggers Jak/Stat signaling cascade and induces p53-dependent antiviral protection.

  2005cites this paper
• BAL 1 / ARTD 9 represses the antiproliferative and pro-apoptotic IFN c – STAT 1 – IRF 1 – p 53 axis in diffuse large B-cell lymphoma

  year unknowncites this paper